Cargando…

MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4

TNF-related apoptosis-inducing ligand (TRAIL), which is a member of the TNF superfamily, can induce tumor cell apoptosis. However, multiple types of tumor, including hepatocellular carcinoma, show tolerance to TRAIL. Previous studies have demonstrated that tumor cells usually change their expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Changlong, Shi, Liang, Chen, Weilai, Fang, Peipei, Li, Jie, Jin, Lingxiang, Pan, Zhenzhen, Pan, Chenwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522038/ https://www.ncbi.nlm.nih.gov/pubmed/28410209 http://dx.doi.org/10.18632/oncotarget.16707

Ejemplares similares

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
por: Pan, Chenwei, et al.
Publicado: (2016)

LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3
por: Fang, Peipei, et al.
Publicado: (2019)

Analysis of Gene Expression of miRNA-106b-5p and TRAIL in the Apoptosis Pathway in Gastric Cancer
por: Pereira, Jéssica, et al.
Publicado: (2020)

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma
por: Geng, Fenghao, et al.
Publicado: (2022)

Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
por: Shi, Bao-Min, et al.
Publicado: (2017)

MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
por: Pan, Chenwei, et al.
Publicado: (2018)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)
por: Thapa, Nikita, et al.
Publicado: (2022)

A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma
por: Liu, Yao, et al.
Publicado: (2012)

The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25
por: Khuu, Cuong, et al.
Publicado: (2016)

The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
por: Gruszka, Renata, et al.
Publicado: (2018)

Apigenin Sensitizes Huh-7 Human Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis
por: Kim, Eun Young, et al.
Publicado: (2012)

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
por: Liang, Chaojie, et al.
Publicado: (2017)

miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis
por: Sun, Chunhui, et al.
Publicado: (2018)

Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer
por: Ma, Sisi, et al.
Publicado: (2017)

Role of phloretin as a sensitizer to TRAIL-induced apoptosis in colon cancer
por: Kim, Jung-Lim, et al.
Publicado: (2022)

The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis
por: van Dijk, Marianne, et al.
Publicado: (2011)

Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
por: Zhang, Baojie, et al.
Publicado: (2019)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

miR-106b suppresses pathological retinal angiogenesis
por: Ménard, Catherine, et al.
Publicado: (2020)

miR-106b as an emerging therapeutic target in cancer
por: Sagar, Surendra Kumar
Publicado: (2021)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process
por: Yau, Wing Lung, et al.
Publicado: (2013)

MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
por: Sun, Yan-ping, et al.
Publicado: (2016)

Perk-dependent repression of miR-106b-25 cluster is required for ER stress-induced apoptosis
por: Gupta, S, et al.
Publicado: (2012)

Up-regulated miR-106b inhibits ox-LDL-induced endothelial cell apoptosis in atherosclerosis
por: Zhang, Yunqing, et al.
Publicado: (2020)

A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese
por: Qi, Fuzhen, et al.
Publicado: (2014)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2012)

TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors
por: Yang, Xi, et al.
Publicado: (2017)

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
por: Liu, Shihai, et al.
Publicado: (2021)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin
por: You, Faping, et al.
Publicado: (2020)

Overexpression of miR-106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1
por: Liu, Zhihu, et al.
Publicado: (2020)

Diagnostic and prognostic value of miR-106a in colorectal cancer
por: Hao, Haibin, et al.
Publicado: (2016)

miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3
por: Gu, Hao, et al.
Publicado: (2019)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
por: Morissette, Mathieu C, et al.
Publicado: (2011)

miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK
por: Zhi, Feng, et al.
Publicado: (2013)

IFN-β sensitizes TRAIL-induced apoptosis by upregulation of death receptor 5 in malignant glioma cells
por: Yoshimura, Sodai, et al.
Publicado: (2019)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
por: Voss, Oliver H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mn57f5qsen8otnosp4bgsk6a3j